Your browser doesn't support javascript.
loading
Replacement of neuraminidase inhibitor-susceptible influenza A(H1N1) with resistant phenotype in 2008 and circulation of susceptible influenza A and B viruses during 2009-2013, South Africa.
Treurnicht, Florette K; Buys, Amelia; Tempia, Stefano; Seleka, Mpho; Cohen, Adam L; Walaza, Sibongile; Glass, Allison J; Rossouw, Inéz; McAnerney, Johanna; Blumberg, Lucille; Cohen, Cheryl; Venter, Marietjie.
Afiliação
  • Treurnicht FK; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Buys A; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Tempia S; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Seleka M; Influenza Program, Centers for Disease Control and Prevention, Pretoria, South Africa.
  • Cohen AL; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • Walaza S; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Glass AJ; Department of Immunization, Vaccines and Biologicals, Global Immunization Monitoring and Surveillance, Expanded Programme on Immunization, World Health Organization, Geneva, Switzerland.
  • Rossouw I; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
  • McAnerney J; Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
  • Blumberg L; Department of Molecular Pathology, Lancet Laboratories, Johannesburg, South Africa.
  • Cohen C; PathCare Laboratories, PathCare Park, Cape Town, South Africa.
  • Venter M; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
Influenza Other Respir Viruses ; 13(1): 54-63, 2019 01.
Article em En | MEDLINE | ID: mdl-30218485
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / Vírus da Influenza B / Farmacorresistência Viral / Inibidores Enzimáticos / Vírus da Influenza A Subtipo H1N1 Limite: Humans País como assunto: Africa Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / Vírus da Influenza B / Farmacorresistência Viral / Inibidores Enzimáticos / Vírus da Influenza A Subtipo H1N1 Limite: Humans País como assunto: Africa Idioma: En Ano de publicação: 2019 Tipo de documento: Article